Lee Ainslie Wave Life Sciences Ltd. Transaction History
Maverick Capital LTD
- $4.82 Billion
- Q3 2024
A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Maverick Capital LTD holds 10,047,520 shares of WVE stock, worth $137 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
10,047,520
Previous 7,669,361
31.01%
Holding current value
$137 Million
Previous $38.3 Million
115.28%
% of portfolio
1.71%
Previous 0.75%
Shares
12 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$249 Million2.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$133 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$92.1 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$84.3 Million48.05% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.86MShares$80.1 Million0.47% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.19B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...